{"id":438898,"date":"2026-01-28T15:38:29","date_gmt":"2026-01-28T15:38:29","guid":{"rendered":"https:\/\/www.newsbeep.com\/ca\/438898\/"},"modified":"2026-01-28T15:38:29","modified_gmt":"2026-01-28T15:38:29","slug":"baseline-roche-intellia-eli-lilly-readout-newsletter","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/ca\/438898\/","title":{"rendered":"Baseline, Roche, Intellia, Eli Lilly: Readout Newsletter"},"content":{"rendered":"<p>Want to stay on top of the science and politics driving biotech today?\u00a0<a href=\"https:\/\/www.statnews.com\/signup\/readout\/\" rel=\"nofollow noopener\" target=\"_blank\">Sign up<\/a>\u00a0to get our biotech newsletter in your inbox.<\/p>\n<p>Good morning. A new startup focused on GLP-1 drugs launched today, but unlike the dozens of other GLP-1 companies, this one isn\u2019t studying weight loss.<\/p>\n<p>The need-to-know this morning<\/p>\n<p>Roche plans to launch Phase 3 studies of its leading obesity candidate this quarter after reporting that the drug <a href=\"https:\/\/www.statnews.com\/2026\/01\/27\/roche-ct388-trials-weight-loss-obesity\/\" rel=\"nofollow noopener\" target=\"_blank\">led to significant weight loss<\/a> in a mid-stage trial.\u00a0<\/p>\n<p>Intellia Therapeutics said the FDA <a href=\"https:\/\/ir.intelliatx.com\/news-releases\/news-release-details\/intellia-therapeutics-announces-fda-lift-clinical-hold-magnitude\" rel=\"noopener nofollow\" target=\"_blank\">lifted a clinical hold<\/a> on a Phase 3 study of its CRISPR gene-editing therapy for a condition called transthyretin amyloidosis, or ATTR, that mostly affects nerves. A clinical hold on a separate Phase 3 study of the therapy in ATTR that affects the heart remains in place.<\/p>\n<p>New startup to develop\u00a0a GLP-1 drug for addiction<\/p>\n<p>A company called Baseline Therapeutics launched today with a focus on studying a GLP-1 drug for various substance use disorders.<\/p>\n<p class=\"restricted-text\">STAT+ Exclusive Story<\/p>\n<p class=\"restricted-login\">Already have an account? <a href=\"https:\/\/www.statnews.com\/login\/\" data-stat-login=\"\" data-stat-paywall-cta=\"breaker login cta\" rel=\"nofollow noopener\" target=\"_blank\">Log in<\/a><\/p>\n<p>\t\t\t<img decoding=\"async\" class=\"restricted-content-breaker-bg\" src=\"https:\/\/www.newsbeep.com\/ca\/wp-content\/uploads\/2025\/10\/stat-plus-breaker-bg.png\" alt=\"STAT+\"\/><\/p>\n<p>\t\t\t\t\t<a href=\"https:\/\/www.statnews.com\/stat-plus\/\" rel=\"nofollow noopener\" target=\"_blank\"><br \/>\n\t\t\t\t\t\t<img decoding=\"async\" class=\"stat-plus-logo\" src=\"https:\/\/www.statnews.com\/wp-content\/themes\/stat\/images\/stat-plus-logo-white.svg\" alt=\"STAT+\"\/><br \/>\n\t\t\t\t\t<\/a><\/p>\n<p>\t\t\t\tThis article is exclusive to STAT+ subscribers<br \/>\n\t\t\t\tUnlock this article \u2014 plus in-depth analysis, newsletters, premium events, and news alerts.<\/p>\n<p class=\"restricted-content-breaker-wrapper-cta mobile\">Already have an account? <a href=\"https:\/\/www.statnews.com\/login\/\" data-stat-login=\"\" data-stat-paywall-cta=\"breaker login cta mobile\" rel=\"nofollow noopener\" target=\"_blank\">Log in<\/a><\/p>\n<p>\t\t\t\t\t\tIndividual plans<\/p>\n<p>\t\t\t\t\t\tGroup plans<\/p>\n<p>\t\t\t\t<a href=\"https:\/\/www.statnews.com\/stat-plus\/\" class=\"stat-button view-all\" data-stat-paywall-cta=\"breaker view all plans\" aria-label=\"View All Plans\" rel=\"nofollow noopener\" target=\"_blank\">View All Plans<\/a><\/p>\n<p class=\"restricted-content-text\">\n\t\t\t\t\t\tTo read the rest of this story subscribe to STAT+.\t\t\t\t\t<\/p>\n<p>\t\t\t\t\t<a href=\"https:\/\/www.statnews.com\/stat-plus\/\" class=\"stat-button restricted-button\" data-stat-paywall-cta=\"breaker subscribe cta 1\" rel=\"nofollow noopener\" target=\"_blank\">Subscribe<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"Want to stay on top of the science and politics driving biotech today?\u00a0Sign up\u00a0to get our biotech newsletter&hellip;\n","protected":false},"author":2,"featured_media":438899,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[34],"tags":[4468,49,48,4863,111202,84,392,994],"class_list":["post-438898","post","type-post","status-publish","format-standard","has-post-thumbnail","category-healthcare","tag-biotechnology","tag-ca","tag-canada","tag-drug-development","tag-drug-prices","tag-health","tag-healthcare","tag-research"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/posts\/438898","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/comments?post=438898"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/posts\/438898\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/media\/438899"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/media?parent=438898"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/categories?post=438898"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/tags?post=438898"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}